Behçet's Disease-related Budd–Chiari Syndrome Successfully Managed with anti-TNF Antibody: A Case Report and Review of the Literature

Keywords

Behçet's disease, infliximab, Budd–Chiari syndrome, vascular involvement, bronchopleural fistula

Abstract

Behçet's disease (BD) is multisystemic vasculitis with heterogeneous clinical manifestations. We describe the case of a 26-year-old man who presented with Budd–Chiari syndrome (BCS) related to BD. The patient received infliximab (IFX) due to the severity of vascular involvement. Subsequently, after IFX therapy, hospital-acquired pneumonia, trapped lung, and fungal infection of the lung and central nervous system developed as complications. The patient benefited from a second course of IFX and clinical remission was achieved following early identification and treatment of complications. Data on the presentation and prognosis of BCS related to BD are extremely limited. Our case report supports the growing evidence that anti-TNF antibody is a promising treatment for BD-related BCS.

 

VIEW THE ENTIRE ARTICLE

Views: 511
HTML downloads: 114
PDF downloads: 393


Published: 2022-08-25
Issue: 2022: Vol 9 No 8 (view)


How to cite:
1.
Erul E, Sandal Uzun G, Koksal D, Keskin O, Uysal S, Inkaya AC, Kalyoncu U. Behçet’s Disease-related Budd–Chiari Syndrome Successfully Managed with anti-TNF Antibody: A Case Report and Review of the Literature. EJCRIM 2022;9 doi:10.12890/2022_003515.

Similar Articles

You may also start an advanced similarity search for this article.